Physician profile
Vincent C Kuo
NPI 1144463183
$796.92
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $121 · 2022: $224 · 2023: $76.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $76.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $76.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $242.03 | 2019-2022 | |
| Qol Medical, LLC | $77.05 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.42 | 2019 | |
| Abbvie INC. | $57.52 | 2023 | |
| Gilead Sciences, INC. | $46.88 | 2019 | |
| Braintree Laboratories, INC. | $30.17 | 2019-2020 | |
| Allergan, INC. | $29.30 | 2019 | |
| Merck Sharp & Dohme LLC | $29.24 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $28.27 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $27.36 | 2019-2020 | |
| Shire North American Group INC | $24.42 | 2019 | |
| Shionogi INC | $24.27 | 2019 | |
| Janssen Biotech, INC. | $23.54 | 2022 | |
| Romark Laboratories, Lc | $21.24 | 2020 | |
| Medtronic, INC. | $18.93 | 2023 | Pillcam |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18.04 | 2019 | |
| Alfasigma USA, INC. | $17.90 | 2020 | |
| Axonics, INC. | $15.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Kuo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.